United States · 
Who invested in Sagent Pharmaceuticals?
Sagent Pharmaceuticals's investors include Vivo Ventures.
200820092010
$53MSeries A$30MSeries A$30MSeries A$40MSeries BUnited States · Series B startup
Who invested in Sagent Pharmaceuticals
4 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Sagent Pharmaceuticals and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$153Mraised across 4 rounds since 2007, from 4 sources
$53MSeries A$30MSeries A$30MSeries A$40MSeries B
- Latest round
- Series B, $40MApr 2010
- Biggest round
- $53MSeries A · Sept 2007
- Step-upi
- 1.3×
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $53M Sept 2007
- Biggest round
- $53M Series A · Sept 2007
- Usual gap between rounds
- 10 months the median of 3
The rounds
- Apr 2010
- Jun 2009
- Sept 2008
- Sept 2007
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Sagent Pharmaceuticals
How much has Sagent Pharmaceuticals raised?
Sagent Pharmaceuticals has raised $153M across 4 rounds since 2007.
When did Sagent Pharmaceuticals last raise?
Sagent Pharmaceuticals's most recent round was a Series B of $40M in Apr 2010.
What was Sagent Pharmaceuticals's biggest round?
Sagent Pharmaceuticals's largest round on record is $53M (Series A), in Sept 2007.
Who backed Sagent Pharmaceuticals first?
Sagent Pharmaceuticals's first round on record, in Sept 2007, was backed by Vivo Ventures.
What stage is Sagent Pharmaceuticals at?
Sagent Pharmaceuticals's latest named round is a Series B, in Apr 2010.
Where is Sagent Pharmaceuticals based?
Sagent Pharmaceuticals is based in the United States.
Companies like Sagent Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.